Results characterized by continued strong commercial momentum and improved operating performance
TORONTO and DALLAS , Aug. 13, 2026 /CNW/ -- Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, announced...
TORONTO and DALLAS , Aug. 13, 2026 /PRNewswire/ -- Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company,...
Health system is first to commercially deploy Claire, the only FDA-approved, AI-enabled imaging device for margin assessment during breast-conserving surgery in the U.S.
TORONTO and DALLAS , June 15, 2026 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, is...
Canadian government-backed contribution supports next-generation AI development for Claire™, Perimeter's flagship intraoperative imaging platform
Conference call/webcast today at 5:00 pm ET
Conference call/webcast today at 5:00 pm ET
TORONTO and DALLAS , May 21, 2026 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, announced...
TORONTO and DALLAS , May 21, 2026 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, announced...